Nationwide Children’s Hospital study identifies potential new pathway for drug development

A newly found understanding of receptor signaling may have revealed a better way to design drugs. A study from Nationwide Children’s Hospital suggests that a newly identified group of proteins, alpha arrestins, may play a role in cell signaling that is crucial to new drug development. The study appears in PLOS ONE.

More than one-third of drugs on the market work by targeting G protein-coupled receptors that control how cells communicate and function. With many hundreds of members, G protein-coupled receptors are the largest family of signaling receptors throughout the body. Full press release here.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Case Western Reserve Univeristy and Cornell University doctors receive nearly $700,000 to fight prematurity-related blindness and lung disorders | Cleveland.com, January 30, 2015

Neuros Medical enrolls first patients in pivotal study for post-amputation pain | Neuros Medical, January 28, 2015

Ohio State cancer center’s former home might house brain, spine hospital | The Columbus Dispatch, January 28, 2015

Exsurco Medical achieves ISO 13485 registration for Medical Device Design & Manufacture | PR Web, January 27, 2015

Shark Tank’s Mark Cuban to join Cincinnati Children’s in startup pitch competition for medical devices and digital health tech | Cincinnati Business Courier, January 27, 2015

Taylor Strategy Partners’ Nicole Plant appointed to the Create Columbus Commission, adding a millennial voice in branding Ohio’s capital as a destination for young professionals | PR Newswire, January 27, 2015

Sen. Sherrod Brown warns against letting Children’s Health Insurance Program expire, Dayton Children’s Hospital | 91.3 WYSO, January 27, 2015

Nationwide Children’s Hospital researchers use video game tech as a method for measurement of upper extremity movement in muscular dystrophy patients | Muscular Dystrophy News, January 26, 2015

$100M development planned in Madisonville near Medpace | Cincinnati Business Courier, January 26, 2015

EnvisionRx and Gilead Sciences sign exclusive agreement to help in the fight against Hepatitis C | Business Wire, January 26, 2015

Sen. Portman and Sen. Baldwin op-ed: The nation needs the Critical Care Assessment and Improvement Act, ensure ability to respond to public health emergencies | The Hill, January 26, 2015

New powered vascular stapler from Ethicon offers greater precision during thoracic surgery | PR Newswire, January 26, 2015

Big Data pioneer Explorys plans to expand in University Circle, adding 80 employees | Cleveland.com, January 26, 2015

Leading with core values, BioOhio member Slone Partners interview with Elizabeth Hutt, CEO, NuGEN | Slone Partners, January 26, 2015

Exsurco Medical, manufacturer of advanced tissue processing devices, now ISO 13485 registered | Morning Journal, January 24, 2015

Repealing medical device tax has bipartisan appeal, Columbus Dispatch Editorial | The Columbus Dispatch, January 24, 2015

Midmark opens exhibit at Versailles Ohio Museum for 100 Year Anniversary | Midmark Corporation, January 23, 2015

Sparton acquires Real-Time Enterprises, developers of embedded software to operate medical devices and diagnostic equipment | Business Wire, January 22, 2015

Invacare Corporation names Matthew E. Monaghan President and Chief Executive Officer | Business Wire, January 22, 2015

VentureOhio appoints executive director from Columbus’ Hicks Partners, Emily Turner | Columbus Business First, January 22, 2015